TP53 disruptive mutation predicts platinum-based chemotherapy and PD-1/PD-L1 blockade response in urothelial carcinomaJOURNAL OF PATHOLOGYIF5.22024-02-212OA
NKG2A and PD-L1 expression panel predicts clinical benefits from adjuvant chemotherapy and PD-L1 blockade in muscle-invasive bladder cancerJOURNAL FOR IMMUNOTHERAPY OF CANCERIF10.62022-05-0515OAAI
Immunosuppressive tumor-associated macrophages expressing interlukin-10 conferred poor prognosis and therapeutic vulnerability in patients with muscle-invasive bladder cancerJOURNAL FOR IMMUNOTHERAPY OF CANCERIF10.62022-03-2551OAAI
Intratumoral CXCL13+CD8+T cell infiltration determines poor clinical outcomes and immunoevasive contexture in patients with clear cell renal cell carcinomaJOURNAL FOR IMMUNOTHERAPY OF CANCERIF10.62021-02-15122OAAI
CCR5 blockade inflames antitumor immunity in BAP1-mutant clear cell renal cell carcinomaCCR5阻断BAP1-mutant透明细胞肾细胞癌的抗肿瘤免疫力JOURNAL FOR IMMUNOTHERAPY OF CANCERIF10.62020-05-0523OAAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向